Balance Sheet
Accounts PayablesCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Current Taxes: 2018-2025

  • Dr Reddys Laboratories' Current Taxes rose 25.00% to $35.0 million in Q1 2025 from the same period last year, while for Mar 2025 it was $35.0 million, marking a year-over-year increase of 25.00%. This contributed to the annual value of $35.0 million for FY2025, which is 25.00% up from last year.
  • Dr Reddys Laboratories' Current Taxes amounted to $35.0 million in Q1 2025, which was up 25.00% from $28.0 million recorded in Q1 2024.
  • Over the past 5 years, Dr Reddys Laboratories' Current Taxes peaked at $35.0 million during Q1 2025, and registered a low of $19.0 million during Q1 2021.
  • For the 3-year period, Dr Reddys Laboratories' Current Taxes averaged around $29.7 million, with its median value being $28.0 million (2024).
  • Data for Dr Reddys Laboratories' Current Taxes shows a peak YoY skyrocketed of 137.50% (in 2021) over the last 5 years.
  • Quarterly analysis of 5 years shows Dr Reddys Laboratories' Current Taxes stood at $19.0 million in 2021, then rose by 10.53% to $21.0 million in 2022, then increased by 23.81% to $26.0 million in 2023, then grew by 7.69% to $28.0 million in 2024, then grew by 25.00% to $35.0 million in 2025.
  • Its Current Taxes stands at $35.0 million for Q1 2025, versus $28.0 million for Q1 2024 and $26.0 million for Q1 2023.